333 related articles for article (PubMed ID: 24627328)
1. Regulation of alternative splicing of tau exon 10.
Qian W; Liu F
Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
[TBL] [Abstract][Full Text] [Related]
2. Tau exon 10 alternative splicing and tauopathies.
Liu F; Gong CX
Mol Neurodegener; 2008 Jul; 3():8. PubMed ID: 18616804
[TBL] [Abstract][Full Text] [Related]
3. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
Wang Y; Wang J; Gao L; Stamm S; Andreadis A
Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
[TBL] [Abstract][Full Text] [Related]
4. Tau alternative splicing in familial and sporadic tauopathies.
Niblock M; Gallo JM
Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
Zhou J; Yu Q; Zou T
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.
Rodriguez-Martin T; Garcia-Blanco MA; Mansfield SG; Grover AC; Hutton M; Yu Q; Zhou J; Anderton BH; Gallo JM
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15659-64. PubMed ID: 16230627
[TBL] [Abstract][Full Text] [Related]
7. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of tau isoform transcripts in sporadic tauopathies.
Connell JW; Rodriguez-Martin T; Gibb GM; Kahn NM; Grierson AJ; Hanger DP; Revesz T; Lantos PL; Anderton BH; Gallo JM
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):104-9. PubMed ID: 15950767
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
Wang Y; Gao L; Tse SW; Andreadis A
Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
[TBL] [Abstract][Full Text] [Related]
10. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
Dawson HN; Cantillana V; Chen L; Vitek MP
J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
[TBL] [Abstract][Full Text] [Related]
11. Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.
Rodriguez-Martin T; Anthony K; Garcia-Blanco MA; Mansfield SG; Anderton BH; Gallo JM
Hum Mol Genet; 2009 Sep; 18(17):3266-73. PubMed ID: 19498037
[TBL] [Abstract][Full Text] [Related]
12. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.
Ray P; Kar A; Fushimi K; Havlioglu N; Chen X; Wu JY
J Mol Neurosci; 2011 Nov; 45(3):453-66. PubMed ID: 21881826
[TBL] [Abstract][Full Text] [Related]
13. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini MG; Van Swieten JC; Goedert M
Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.
Bowles KR; Pugh DA; Oja LM; Jadow BM; Farrell K; Whitney K; Sharma A; Cherry JD; Raj T; Pereira AC; Crary JF; Goate AM
Acta Neuropathol; 2022 Feb; 143(2):225-243. PubMed ID: 34874463
[TBL] [Abstract][Full Text] [Related]
15. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
[TBL] [Abstract][Full Text] [Related]
16. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
17. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
18. The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.
Iovino M; Pfisterer U; Holton JL; Lashley T; Swingler RJ; Calo L; Treacy R; Revesz T; Parmar M; Goedert M; Muqit MM; Spillantini MG
Acta Neuropathol; 2014 Feb; 127(2):283-95. PubMed ID: 24292008
[TBL] [Abstract][Full Text] [Related]
19. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
Yu Q; Guo J; Zhou J
J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
[TBL] [Abstract][Full Text] [Related]
20. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
Kalbfuss B; Mabon SA; Misteli T
J Biol Chem; 2001 Nov; 276(46):42986-93. PubMed ID: 11560926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
